Ignite Creation Date:
2024-05-06 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06029452
Status:
COMPLETED
Last Update Posted:
2024-02-21
First Post:
2023-09-01
Brief Title:
A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy Attrwt-CM And Non-Amyloid Heart Failure Among Patients With Heart Failure HF
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Retrospective Chart Validation Study Evaluating the Performance of Machine Learning Algorithm ML to Predict the Clinical Diagnosis of Wild-type Transthyretin Amyloid Cardiomyopathy ATTRwt-CM and Non-amyloid Heart Failure Among Patients With Heart Failure HF
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an observational retrospective non-inferiority study with a study sample from a large national database
A machine learning ML model will use a national database to predict the clinical diagnosis of ATTRwt-CM among HF patients This study will include HF patients 50 years old
A machine learning ML model will use a national database to predict the clinical diagnosis of ATTRwt-CM among HF patients This study will include HF patients 50 years old
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None